Kropz Interim Results: Production Ramp-Up Challenges and New Nanophos Revenue Stream

Kropz interim results: ramp-up pains, record months and a fresh Nanophos angle

Kropz’s half-year update to 30 September 2025 is a tale of steady operational problem-solving at Elandsfontein, a modest step up in revenue, and continued reliance on shareholder funding while the mine ramps toward break-even. There’s also a new twist: “Nanophos” – a previously discarded fraction now generating sales.

Here’s what stood out, why it matters, and what I’ll be watching next.

Key numbers at a glance

Elandsfontein’s ramp-up: fixes start to bite, but costs still elevated

All revenue remains “trial production” while Elandsfontein ramps. The mine had to re-engineer parts of its fines flotation circuit after encountering different particle size distribution in the ore. That, plus ore variability and limited operator experience, pushed volumes and yields below plan and forced Kropz to discount product to win market share and reflect lower grades.

Management has attacked the bottlenecks. A new flotation cell (the “Turbocell”) with performance guarantees is installed and delivering good results. Throughput has been constrained by slimes (ultra-fine material), so a new centrifuge is in place and improving handling capacity. A dedicated wash plant for the tricky “Pink Ore” variant has been commissioned and is improving yields. These moves matter because better recoveries and steadier grades should lift realised pricing and drag unit costs down.

Post period, production visibly improved: 64,925 tonnes produced in October-November, with a record 35,565 tonnes in November. That indicates the fixes are starting to translate into output. But Kropz is clear: Elandsfontein has not reached break-even production levels yet, and further challenges may arise.

Pricing, sales and customer qualification: discounting now, potential upside later

Kropz sold 128,708 tonnes of phosphate concentrate in the half, generating US$ 15.4 million (up from US$ 14.1 million). Sales volumes lagged expectations due to limited stock on hand. As a new entrant, the company discounted prices and sold lower-grade product during ramp-up, which weighed on margins. The gross loss was US$ 7.4 million, and operating loss US$ 12.7 million.

There are signs the price-quality dynamic could improve. Kropz’s rock phosphate has now been qualified with customers in South Korea, Australia, New Zealand and Brazil across single superphosphate (SSP) and phosphoric acid producers. The company is focusing on those markets where its rock’s low cadmium, toxic metals, moisture, odour and CaO levels are a selling point. As quality stabilises and market reputation builds, management expects better realisations. Not guaranteed, but directionally encouraging.

Nanophos: a new product from a waste stream

Here’s the interesting new lever. The centrifuge solution didn’t just de-bottleneck throughput; it unlocked an additional product stream: “Nanophos”, a sub 38-micron fraction previously treated as waste. With minimal processing it can be sold, and can also be granulated for higher value. First Nanophos sales of US$ 0.3 million were booked in the period.

Why it matters: turning waste into revenue increases recovery and broadens the product offering with relatively low incremental cost. The granulation angle could enhance margins if volumes build. It’s early days, but this is exactly the sort of operational creativity that can move the P&L in a ramp-up.

Funding and balance sheet: supportive shareholder, but a material uncertainty remains

Cash was US$ 3.5 million at period end, with inventory up to US$ 9.5 million. Payables rose to US$ 14.5 million. Shareholder loans and derivatives totalled US$ 80.1 million. During the half, Kropz Elandsfontein fully drew two ARC Fund loan facilities of ZAR 130 million and ZAR 200 million, both at South African prime plus 6% and repayable on demand with 15 business days’ notice.

Post period, ARC provided a third facility of ZAR 250 million (approximately US$ 14.4 million) on the same terms, with ZAR 150 million still available to draw at the date of the report. Management notes the group may need future fundraisings until break-even is achieved. ARC has indicated it does not intend to recall its loans within 12 months from the interim report date, which helps, but the on-demand nature and high interest rate keep financial risk elevated.

Bottom line: supportive shareholder, but the going concern statement flags a material uncertainty. Execution on throughput, yields and pricing is critical to reduce funding dependence.

Hinda (RoC): smaller first step under assessment

Hinda remains in study mode. The company is assessing a reduced-sized, fit-for-purpose, lower capex project to prove the production-and-export concept in the Republic of Congo. The feasibility update is ongoing, with engagement across government, suppliers, and contractors. Funding solutions are still being identified – not disclosed at this stage.

Legal and permitting watch-outs

• WWF-SA’s lawsuit against the South African Ministry over an environmental offset exemption tied to Elandsfontein is ongoing. Kropz intends to oppose as third respondent.
• Separate litigation from Teh Hong Eng Investments and Meridian regarding Cominco share acquisition rights is stayed until 31 March 2026; Kropz plans to defend.
• Port access at Saldanha: Kropz has a draft agreement with Transnet but it is not signed; shipments to date incurred guest port charges. Signing would remove a practical uncertainty.

My take: cautious progress with real operating momentum

There’s enough in here to justify cautious optimism. The Turbocell, centrifuge and Pink Ore wash plant are translating into better production, and customer qualification in key markets sets the stage for improved pricing as quality steadies. Nanophos is a neat recovery win with optionality via granulation.

The flip side is clear: the business is loss-making at current run-rates, reliant on on-demand, high-cost shareholder funding, and still ironing out processing challenges. Legal noise and the unsigned port agreement add risk. This is still a ramp-up story where execution will drive value.

What to watch next quarter

• Monthly production and sales – can Kropz sustain or improve on November’s 35,565 tonnes?
• Realised pricing – any evidence of discounts narrowing as grades and reputation improve.
• Unit costs – signs that economies of scale and higher yields are reducing cost per tonne.
• Nanophos – volumes, granulation progress, and pricing uplift.
• Funding – remaining drawdowns on the ZAR 250 million facility and any new funding moves.
• Port access – progress from draft to signed agreement with Transnet.
• Legal updates – developments in the WWF-SA matter and the Cominco-related litigation.

If Kropz can string together several months of stronger throughput and better realised prices, the path to break-even becomes much clearer. Until then, expect bumps along the way as the plant learns the ore body and the balance sheet leans on ARC. For company materials and future updates, see kropz.com.